J. Wood

发表

Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage

B. Bahr, A. Makriyannis, D. Karanian, 2007, Journal of Pharmacology and Experimental Therapeutics.

Conformationally constrained analogues of 2-arachidonoylglycerol.

A. Makriyannis, J. Wood, R. Duclos, 2007, Bioorganic & medicinal chemistry letters.

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma

A. Makriyannis, J. Wood, John S. Williams, 2010, Journal of Lipid Research.

Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite

M. Malamas, A. Makriyannis, J. Wood, 2020, Frontiers in Pharmacology.

A neutral CB1 receptor antagonist reduces weight gain in rat.

Q. Pittman, J. Wood, K. Sharkey, 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats

A. Makriyannis, J. Wood, S. Vadivel, 2013, Psychopharmacology.

Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.

M. Malamas, B. Bahr, A. Makriyannis, 2019, Bioorganic & medicinal chemistry.

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

B. Bahr, A. Makriyannis, D. Karanian, 2012, Neurotherapeutics.

The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat

Lindsay K. Eller, J. Wood, R. Reimer, 2011, Pharmacology Biochemistry and Behavior.

Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113

J. Salamone, A. Makriyannis, J. Wood, 2009, Pharmacology Biochemistry and Behavior.

Design and Synthesis of Highly Potent and Specific ABHD6 Inhibitors

M. Malamas, A. Makriyannis, J. Wood, 2021, ChemMedChem.

( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes.

K. Mackie, L. Marnett, A. Hohmann, 2018, Journal of medicinal chemistry.

Oximes short-acting CB1 receptor agonists.

M. Malamas, J. Wood, Han Zhou, 2018, Bioorganic & medicinal chemistry.

Maternal Dietary Fatty Acids and Their Relationship to Derived Endocannabinoids in Human Milk

S. Nikas, A. Makriyannis, J. Wood, 2021, Journal of human lactation : official journal of International Lactation Consultant Association.

Endocannabinoid Metabolome Characterization of Transitional and Mature Human Milk

A. Makriyannis, J. Wood, Fan Zhang, 2018, Nutrients.

C-ring cannabinoid lactones: a novel cannabinergic chemotype.

S. Nikas, A. Makriyannis, J. Wood, 2014, ACS medicinal chemistry letters.

Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.

A. Makriyannis, J. Wood, N. Zvonok, 2012, Journal of proteome research.

A New Generation Fatty Acid Amide Hydrolase Inhibitor Protects Against Kainate-Induced Excitotoxicity

B. Bahr, S. Nikas, S. O. Alapafuja, 2011, Journal of Molecular Neuroscience.

Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.

B. Bahr, A. Makriyannis, D. Karanian, 2007, Analytical chemistry.

Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells

A. Makriyannis, J. Wood, H. Avraham, 2007, PloS one.

Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats

A. Makriyannis, J. Wood, S. Vadivel, 2014, Psychopharmacology.

Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study

P. Oprocha, A. Makriyannis, W. Krajewska, 2013, PloS one.

Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist.

A. Makriyannis, J. Wood, D. Janero, 2013, Life sciences.

Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells

A. Makriyannis, J. Wood, John S. Williams, 2007, PloS one.

A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists.

J. Wood, T. Coderre, P. Schiller, 2016, Journal of medicinal chemistry.

Heteroadamantyl cannabinoids.

Anna L. Bowman, M. Tius, J. Wood, 2010, Journal of medicinal chemistry.

An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.

J. Wood, Wanying Zhu, Clinton E. Canal, 2015, ACS chemical neuroscience.

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

B. Bahr, A. Makriyannis, D. Karanian, 2012, Neurotherapeutics.

Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward

M. Pistis, M. Malamas, J. Wood, 2019, Neuropharmacology.

Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress.

John M. Davis, A. Makriyannis, J. Wood, 2015, The journal of pain : official journal of the American Pain Society.

Controlled-deactivation cannabinergic ligands.

S. Nikas, A. Makriyannis, J. Wood, 2013, Journal of medicinal chemistry.

Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters

Alexandros Makriyannis, Paul Vouros, A. Makriyannis, 2008, Clinical chemistry and laboratory medicine.

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

J. Salamone, J. Wood, G. Thakur, 2008, Neuropsychopharmacology.

Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects

A. Hohmann, A. Makriyannis, J. Wood, 2011, Pharmacology Biochemistry and Behavior.

Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

M. Malamas, A. Makriyannis, J. Wood, 2019, Bioorganic & medicinal chemistry.

A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models

A. Makriyannis, J. Wood, C. Limebeer, 2016, Psychopharmacology.

Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054

J. Salamone, J. Wood, G. Thakur, 2013, Pharmacology Biochemistry and Behavior.

Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387

J. Salamone, J. Wood, K. Ishiwari, 2006, Pharmacology Biochemistry and Behavior.

Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth.

Ana Rodriguez, Z. Wawrzak, J. Wood, 2013, Journal of medicinal chemistry.

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists.

S. Nikas, A. Makriyannis, J. Wood, 2021, European journal of medicinal chemistry.

Probing the Carboxyester Side Chain in Controlled Deactivation (−)-Δ8-Tetrahydrocannabinols

Rishi Sharma, S. Nikas, A. Makriyannis, 2014, Journal of medicinal chemistry.

Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats

A. Makriyannis, J. Wood, V. K. Vemuri, 2008, Pharmacology Biochemistry and Behavior.

Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands

L. Allen, S. Nikas, A. Makriyannis, 2019, Current developments in nutrition.

Postpartum changes in the endocannabinoid metabolome of human breast milk

A. Makriyannis, J. Wood, S. Vadivel, 2013 .

Antitrypanosomal Lead Discovery: Identification of a Ligand-Efficient Inhibitor of Trypanosoma cruzi CYP51 and Parasite Growth

Ana Rodriguez, Z. Wawrzak, J. Wood, 2013 .

Probing the Carboxyester Side Chain in Controlled Deactivation (−)-Δ8-Tetrahydrocannabinols

Rishi Sharma, S. Nikas, A. Makriyannis, 2014, Journal of medicinal chemistry.

A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models

A. Makriyannis, J. Wood, C. Limebeer, 2016, Psychopharmacology.